1. Dose adjustment of carboplatin in patients on hemodialysis
   Achuta K. Guddati et al, 2014, Medical Oncology CrossRef
2. MWCNT modified glassy carbon electrode in presence of cationic surfactant for the electro-analysis of paclitaxel
   Jayant I. Gowda et al, 2021, Results in Chemistry CrossRef
3. Over a decade of experience with carboplatin therapeutic drug monitoring in a childhood cancer setting in the United Kingdom
   Shelby Barnett et al, 2021, British Journal of Clinical Pharmacology CrossRef
4. Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis
   Nan Zhang et al, 2023, OncoTargets and Therapy CrossRef
5. Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: A case report
   Takuma Wada et al, 2016, Biomedical Reports CrossRef
6. Chemotherapy in chronic kidney disease and dialysis
   SABINE KARAM et al, 2020, Onco-Nephrology CrossRef
7. Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure
   Ken-ichi Fujita et al, 2019, Current Drug Metabolism CrossRef
8. Advanced Thymic Cancer Treated with Carboplatin and Paclitaxel in a Patient Undergoing Hemodialysis
   Satoru Miura et al, 2015, Internal Medicine CrossRef
9. Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report
   Masahiro Kondo et al, 2018, Journal of Pharmaceutical Health Care and Sciences CrossRef
10. Treatment of advanced ovarian cancer with carboplatin and paclitaxel in a patient undergoing hemodialysis: Case report and literature review
    Qing Yang et al, 2022, Hemodialysis International CrossRef
11. Cancer screening and treatment in patients with end-stage renal disease: remaining issues in the field of onco-nephrology
    Yuichiro Kitai et al, 2016, Renal Replacement Therapy CrossRef